0 Yorum
0 Paylar
101 Görüntüleme
Arama
Yeni insanlar keşfedin, yeni bağlantılar kurun ve yeni arkadaşlar edinin
-
Haber Akışı
- KEŞFEDIN
-
Sayfalar
-
Gruplar
-
Etkinlikler
-
Bloglar
-
Beğenmek, paylaşmak ve yorum yapmak için lütfen giriş yapın!
-
Herceptin Biosimilars Market Size, Share, Trends, Industry Analysis and Forecast to 2030"Herceptin Biosimilars Market Summary: According to the latest report published by Data Bridge Market Research, the Herceptin Biosimilars Market CAGR Value Data Bridge Market Research analyses that the market which was USD 1,810 million in 2022, would rocket up to USD 11,302 million by 2030 and is expected to undergo a CAGR of 23.2% during the forecast period. ...0 Yorum 0 Paylar 482 Görüntüleme
-
Oncology Biosimilars Market Growth Analysis by Product, Application and Region"Oncology Biosimilars Market Summary According to the latest report published by Data Bridge Market Research, the Oncology Biosimilars Market Global oncology biosimilars market size was valued at USD 6.66 billion in 2024 and is projected to reach USD 25.88 billion by 2032, with a CAGR of 18.5% during the forecast period of 2025 to 2032. An influential Oncology Biosimilars...0 Yorum 0 Paylar 300 Görüntüleme
-
Oncology Immunotherapy Biosimilars Market Analysis: Top Trends Defining Future Industry Success" According to the latest report published by Data Bridge Market Research, the Oncology Immunotherapy Biosimilars Market The global Oncology Immunotherapy Biosimilars market size was valued at USD 891 Million in 2025 and is expected to reach USD 1828.16 Million by 2033, at a CAGR of 9.40% during the forecast period. Oncology Immunotherapy Biosimilars Market report has been...0 Yorum 0 Paylar 342 Görüntüleme
-
Ophthalmology Anti-VEGF Biosimilars Market Size, Share, Trends, Industry Analysis and Forecast by 2033"Latest Insights on Executive Summary Ophthalmology Anti-VEGF Biosimilars Market Share and Size CAGR Value The global ophthalmology Anti-VEGF biosimilars market size was valued at USD 475.2 Million in 2025 and is expected to reach USD 958.74 Million by 2033, at a CAGR of 9.17% during the forecast period The market insights gained through this...0 Yorum 0 Paylar 624 Görüntüleme
-
Biosimilars Market Trends: Why Patent Expirations Are Creating New Opportunities for Biosimilar DrugsBiosimilars Market: Interchangeability, Patent Expiry and the Checkpoint Inhibitor Pipeline The Biosimilars Market comprises biological medicines shown to be highly similar to an already approved reference biologic, with no clinically meaningful differences in safety, purity or potency. In the US, they are approved through the abbreviated 351(k) pathway established under the Biologics Price...0 Yorum 0 Paylar 63 Görüntüleme
Sponsor
